Literature DB >> 6837521

Heterogeneity of serum creatine kinase activity among racial and gender groups of the population.

E T Wong, C Cobb, M K Umehara, G A Wolff, L J Haywood, T Greenberg, S T Shaw.   

Abstract

To develop reference ranges for creatine kinase (CK) appropriate for the patient population served by this hospital, levels of serum CK were measured in 1,537 individuals in our employee population. There was substantial heterogeneity in mean, median, and range of CK levels among the several race/gender subgroups in the population studied. The race/gender subgroups could be placed into three broad groups: a high CK group, composed solely of black men; an intermediate CK group, consisting of nonblack men plus black women; and a low CK group, comprised of nonblack women. Mean CK level of the high CK group was twice that of the intermediate CK group, which, in turn, was twice that of the low CK group. Differences in mean CK values among the subgroups placed into either the intermediate CK group or the low CK group were not significant when tested with analysis of variance. Therefore, practical reference ranges for these groups are as follows: 52-520 U/L for the high CK group; 35-345 U/L for the intermediate CK group; and 25-145 U/L for the low CK group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837521     DOI: 10.1093/ajcp/79.5.582

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  26 in total

1.  Reference intervals for serum creatine kinase in athletes.

Authors:  Vassilis Mougios
Journal:  Br J Sports Med       Date:  2007-05-25       Impact factor: 13.800

2.  Racial variation in serum creatine kinase levels.

Authors:  J D Johnston; M Lloyd; J A Mathews; S W Hawthorne
Journal:  J R Soc Med       Date:  1996-08       Impact factor: 5.344

3.  Race-gender differences in serum creatine kinase activity: a study among South Africans.

Authors:  R F Gledhill; C A Van der Merwe; M Greyling; M M Van Niekerk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

4.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

Review 5.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

6.  Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview.

Authors:  Spyridon Klinis; Athanasios Symeonidis; Dimitrios Karanasios; Emmanouil K Symvoulakis
Journal:  Biomed Rep       Date:  2016-11-30

Review 7.  Creatine kinase: race-gender differences in patients hospitalized for suspected myocardial infarction.

Authors:  J C Cook; E Wong; L J Haywood
Journal:  J Natl Med Assoc       Date:  1990-04       Impact factor: 1.798

8.  Hypertension risk in idiopathic hyperCKemia.

Authors:  Lizzy M Brewster; Sjoerd van Bree; Jaap C Reijneveld; Nicolette C Notermans; W M Monique Verschuren; Joseph F Clark; Gert A van Montfrans; Marianne de Visser
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

9.  Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Approach to asymptomatic creatine kinase elevation.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Cleve Clin J Med       Date:  2016-01       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.